Loperamide Abuse Triggers Look At Potential Label Warning
This article was originally published in The Tan Sheet & The Rose Sheet
Executive Summary
Monitoring of AERs prompts concern about the ingredient used in OTC anti-diarrheal products, CDER says a day after it noted adverse event reports in announcing concerns about a risk of serious bleeding linked to use of OTC antacid/aspirin products.